Biomedical engineers have traditionally developed technologies in response to the needs of
the developed world's medical community. As a result, the diagnostic systems on which they …

Multidrug-resistant tuberculosis (MDR-TB), caused by Mycobacterium tuberculosis that is
resistant to both isoniazid and rifampicin with or without resistance to other drugs, is a …

Priority setting of health interventions is often ad-hoc and resources are not used to an
optimal extent. Underlying problem is that multiple criteria play a role and decisions are …

Background Even when tuberculosis (TB) treatment is free, hidden costs incurred by patients
and their households (TB-affected households) may worsen poverty and health. Extreme TB …

Background The Xpert MTB/RIF test enables rapid detection of tuberculosis (TB) and
rifampicin resistance. The World Health Organization recommends Xpert for initial diagnosis …

Objective To determine the costs and benefits of interventions for maternal and newborn
health to assess the appropriateness of current strategies and guide future plans to attain …

Cost-effectiveness analysis (CEA) is increasingly important in public health decision making,
including in low-and middle-income countries. The decision makers' valuation of a unit of …

Background Around 0.4 million cases of multidrug-resistant tuberculosis (MDR-TB) occur
each year. Only a small fraction of these cases are treated according to international …

Interventions in the energy sector offer significant opportunities for reducing both
greenhouse and other health-damaging pollution, resulting in what are called “co-benefits.” …

For nearly a century, the tuberculin skin test was the only tool available for the detection of
latent tuberculosis infection. A recent breakthrough has been the development of T-cell …